Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

New and experimental HIV treatments news

Show

From To
Fighting AIDS: An Oral History

In this week's video endorsement, June Thomas and Dana Stevens discuss a compelling trove of videos that amount to an oral history of the AIDS activist group, ACT UP.

Published
07 October 2010
From
Slate
Animal study reveals possible method for boosting the immune system to protect infants against HIV

The researchers boosted HIV-specific neutralizing antibodies that are passed across the placenta at birth. The infant monkeys developed higher levels of neutralizing antibodies and had lower levels of disease in their blood.

Published
03 October 2010
From
EurekAlert!
Norwegian Bionor Pharma to discontinue HIV vaccine development

Norwegian company Bionor Pharma ASA said today it will not continue the development of its cell-mediated therapeutic HIV-vaccine candidate Vacc-4x as the results from the phase IIb trial with it were disappointing.

Published
01 October 2010
From
ADP News
A drug against AIDS could be effective against the herpesvirus

Scientists have shown that raltegravir, the drug approved in 2007 for the treatment of AIDS that is sold by Merck under the name Isentress, cancels the function of an essential protein for the replication of one kind of herpes virus.

Published
23 September 2010
From
Science Daily
Cytheris initiates INSPIRE 3, a phase II clinical trial of recombinant human interleukin-7 (CYT107) in chronically infected HIV patients

Study will assess safety and biological activity of repeated cycles of CYT107 administered to restore and maintain CD4 T-lymphocyte counts above 500 cells/µL in HIV immune non-responding patients with CD4 counts remaining between 101-350 cells/µL after at least 2 years of HAART.

Published
22 September 2010
From
Cytheris
Taribavirin offers a safe, effective alternative for chronic hepatitis C

Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response in patients with chronic hepatitis C.

Published
22 September 2010
From
Eurekalert Medicine & Health
Scientists reveal HIV cell mystery

Australian scientists have discovered how HIV enters `resting cells`. The discovery could pave the way for identifying drugs that could block HIV entry into resting ceklls, bring a cure for HIV infection one step closer.

Published
21 September 2010
From
The Age
ICAAC: Novel HIV drug a 'trade-off'

Published
17 September 2010
From
MedPage Today
Poor adherence, high viral loads help explain rilpivirine treatment failures

Published
17 September 2010
From
AIDSMeds.com
Raltegravir Pharmacokinetics Disrupted by Antacids in Healthy Patients With HIV: Presented at ICAAC

If individuals with HIV ingest common over-the-counter antacids at the same as taking raltegravir, there may be changes in the pharmacokinetics of the antiretroviral drug.

Published
16 September 2010
From
Doctor's Guide

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.